Literature DB >> 27913978

Case Series Study of Invasive Pulmonary Aspergillosis.

Ana I Aller-García1, Carmen Castro-Méndez2, Ana Alastruey-Izquierdo3, Elena M Marín-Martínez2, Ismail Zakariya-Yousef Breval2, Carmen Couto-Caro4, Juan C López-Marín4, Nicolás Peña-Griñán5, Maite Ruiz de Pipaon6, Ana M Romero-Mejías2, Estrella Martín-Mazuelos2.   

Abstract

Diagnosis of invasive pulmonary aspergillosis (IPA) is challenging. The objective of the study was to assess the value of microbiological tests to the diagnosis of IPA in the absence of non-specific radiological data. A retrospective study of 23 patients with suspicion of IPA and positivity of some microbiological diagnostic tests was performed. These tests included conventional microbiological culture, detection of Aspergillus galactomannan (GM) antigen and in some patients (1 → 3)-β-D-glucan (BDG) and Aspergillus fumigatus DNA using the LightCycler® SeptiFast test. In 10 patients with hematological malignancy, 6 cases were considered 'probable' and 4 'non-classifiable.' In 8 patients with chronic lung disease, 7 cases were classified as 'probable' and 1 as 'proven,' and in 5 patients with prolonged ICU stay (>7 days), there were 2 'proven' cases, 2 'non-classifiable' and 1 putative case. Microbiological culture was positive in 17 cases and 18 Aspergillus spp. were isolated (one mixed culture). A. fumigatus was the most frequent (44.4%) followed by A. tubingensis. The Aspergillus galactomannan (GM) antigen assay was positive in 21 cases (91.3%). The GM antigen and the (1 → 3)-β-D-glucan (BDG) assays were both performed in 12 cases (52.2%), being positive in 9. The SeptiFast test was performed in 7 patients, being positive in 4. In patients with non-classifiable pulmonary aspergillosis and one or more positive microbiological tests, radiological criteria may not be considered a limiting factor for the diagnosis of IPA.

Entities:  

Keywords:  (1 → 3)-β-D-glucan; Chronic lung disease; Galactomannan antigen; Hematological malignancy; Invasive pulmonary aspergillosis; Microbiological culture; Prolonged ICU stay; SeptiFast test

Mesh:

Year:  2016        PMID: 27913978     DOI: 10.1007/s11046-016-0097-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  30 in total

1.  Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

Authors:  Marcio Nucci; Simone Aranha Nouér; Monica Grazziutti; Naveen Sanath Kumar; Bart Barlogie; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

Review 2.  ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.

Authors:  O Marchetti; F Lamoth; M Mikulska; C Viscoli; P Verweij; S Bretagne
Journal:  Bone Marrow Transplant       Date:  2011-09-19       Impact factor: 5.483

3.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.

Authors:  Stijn I Blot; Fabio Silvio Taccone; Anne-Marie Van den Abeele; Pierre Bulpa; Wouter Meersseman; Nele Brusselaers; George Dimopoulos; José A Paiva; Benoit Misset; Jordi Rello; Koenraad Vandewoude; Dirk Vogelaers
Journal:  Am J Respir Crit Care Med       Date:  2012-04-19       Impact factor: 21.405

4.  Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast.

Authors:  J Steinmann; J Buer; P-M Rath; A Paul; F Saner
Journal:  Transpl Infect Dis       Date:  2009-02-05       Impact factor: 2.228

5.  Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis.

Authors:  Rime Barouky; Michel Badet; Marc Saint Denis; Jean Luc Soubirou; François Philit; Claude Guerin
Journal:  Eur J Intern Med       Date:  2003-10       Impact factor: 4.487

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 7.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  P Bulpa; A Dive; Y Sibille
Journal:  Eur Respir J       Date:  2007-10       Impact factor: 16.671

Review 8.  Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature.

Authors:  P Samarakoon; A O Soubani
Journal:  Chron Respir Dis       Date:  2008       Impact factor: 2.444

9.  Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.

Authors:  R Y Hachem; D P Kontoyiannis; R F Chemaly; Y Jiang; R Reitzel; I Raad
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

10.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  Nuri Tutar; Gokhan Metan; Ayşe Nedret Koç; Insu Yilmaz; Ilkay Bozkurt; Zuhal Ozer Simsek; Hakan Buyukoglan; Asiye Kanbay; Fatma Sema Oymak; Inci Gulmez; Ramazan Demir
Journal:  Multidiscip Respir Med       Date:  2013-09-04
View more
  2 in total

Review 1.  The Endless Wars: Severe Fever With Thrombocytopenia Syndrome Virus, Host Immune and Genetic Factors.

Authors:  Min Wang; Weilong Tan; Jun Li; Liqun Fang; Ming Yue
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

Review 2.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.